-640x360.webp&w=3840&q=75)
Genesis Energy appoints Emma Oettli as CFO
Genesis Energy (ASX:GNE) appointed Emma Oettli as its new CFO, effective April 15.
Jon Cuthbert
Founder & COOJon is a former international magazine editor with a strong background in business publications (print and digital) in the Middle East and Australia.
Contact
Contact editorial teamArticles by Jon Cuthbert
Aurelia Metals secures $150M to fuel copper growth
Aurelia Metals (ASX:AMI) announced an oversubscribed $150 million senior secured financing package.
Pure Resources partners with Rice University for AI cooling
Pure Resources (ASX:PR1) has tapped Texas-based Rice University to develop advanced carbon nanotube fibre heat sink architectures.
Technology
Electro Optic Systems secures US and Korean defence contracts
Electro Optic Systems (ASX:EOS) secured two new defence contracts in the United States and a milestone in a conditional South Korean deal.
Communications
Jackie O launches $82M lawsuit against ARN Media
Radio star Jacqueline ‘Jackie O’ Henderson has launched a massive $82.3 million legal battle against ARN Media (ASX:ARN).
Nike posts flat Q3 fiscal 2026 revenue of $11.3B
NIKE (NYSE:NKE) reported financial results for its fiscal 2026 third quarter ended February 28, 2026, on Tuesday, March 31, 2026.
Technology
Forum Markets posts $6.5M 2025 revenue along with large GAAP net loss
Forum Markets (NASDAQ:FRMM), a fintech company focused on real-world asset tokenization, reported its fourth-quarter and full-year 2025 financial results and provided 2026 guidance on its scaling RWA platform.
Technology
SPAR Group issues robust 2026 guidance as strategic cost reset drives margin expansion
SPAR Group (NASDAQ:SGRP) issued optimistic financial guidance for fiscal year 2026 on Tuesday, March 31, 2026, signaling a major turn toward higher profitability and operational efficiency.
Palvella Therapeutics reveals positive Phase 3 SELVA results and upsized $216M financing
Palvella Therapeutics (NASDAQ:PVLA) reported transformative full-year 2025 financial results and a significant corporate update on March 31, 2026, headlined by the successful clinical validation of its lead rare disease program.
Technology
TD SYNNEX reports record Q1 revenue of $17.2B as AI infrastructure demand surges
TD SYNNEX (NYSE:SNX) reported exceptional financial results for the fiscal first quarter ended February 28, 2026, significantly outperforming its previous guidance across all major metrics.